Abantel 250 mg/10 mg, tableta za ovce
  • CLOSANTEL SODIUM
  • ABAMECTIN
  • Valid
Authorised in these countries:
  • Croatia
Export to PDF

Product identification

Medicine name:
Abantel 250 mg/10 mg, tableta za ovce
Active substance and strength:
  • CLOSANTEL SODIUM
    250.00
    milligram(s)
    /
    250.00
    Tablet
  • ABAMECTIN
    10.00
    milligram(s)
    /
    10.00
    Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP54AA52
Authorisation number:
  • UP/I-322-05/12-01/607
Product identification number:
  • cb3bcac8-caf6-4010-95af-c62e7f9fa99c
Permanent identification number:
  • 600000065157

Product details

Legal status of supply:
This information is not available for this product.
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Sheep
      • Meat and offal, milk
        35
        day
  • Oral use
    • Sheep
      • Meat and offal, milk
        35
        milligram(s)/kilogram

Availability

Package description:
Manufacturing sites for batch release:
  • Biovet AD
Source wholesaler:
This information is not available for this product.
Destination wholesaler:
This information is not available for this product.

Authorisation details

Authorisation status:
  • Valid
Authorisation procedure type:
  • Marketing Authorisation
Procedure number:
This information is not available for this product.
Date of authorisation status change:
Legal basis of product authorisation:
  • Complete application (stand-alone)
Authorisation country:
  • Croatia
Responsible authority:
  • Ministry Of Agriculture, Veterinary And Food Safety Directorate
Marketing authorisation holder:
  • Genera d.d.
Marketing authorisation issued:
Reference member state:
This information is not available for this product.
Concerned member states:
This information is not available for this product.
Reference product identifier:
This information is not available for this product.
Source product identifier:
This information is not available for this product.

Additional information

To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet

Documents

Summary of Product Characteristics (PDF)
First published:
Last updated:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."